DOI QR코드

DOI QR Code

Preventive effect of fermented red ginseng on cisplatin-induced nephrotoxicity mouse

Cisplatin으로 유도된 신손상 마우스 모델에 대한 발효홍삼의 예방효능

  • Hyun, Ja-Kyoung (College of Korean Medicine, Daejeon University) ;
  • Kwon, O Jun (Gyeongbuk Regional industry Evaluation, Daegyeong Institute for Regional Program Evaluation) ;
  • Lee, Joo Young (College of Korean Medicine, Daegu Haany University) ;
  • Roh, Seong-Soo (College of Korean Medicine, Daegu Haany University) ;
  • Seo, Young-Bae (College of Korean Medicine, Daejeon University)
  • Received : 2016.02.03
  • Accepted : 2016.03.03
  • Published : 2016.06.30

Abstract

Red ginseng is known to have many beneficial effects. Cisplatin, an effective antineoplastic drug, can cause many side effects like irreversible sensorineural hearing loss and serious tinnitus in humans. This study is aimed to reduce a cisplatin's side effect, nephrotoxicity by fermentated korean red ginseng. Korea ginseng was produced by steaming and dring and fermentation. And mice were divided into 4 groups- (A) normal mice, (B) Vehicle treated cisplatin mice, (C) RG0F0-treated cisplatin mice, (D) RG8F3-treated cisplatin mice. C and D groups were feed each material 200 mg/kg/day during 4 days. And cisplatin 20 mg/kg injected to B, C, and D groups as abdominal injection. After 24 h, blood sample was collected. The kidneys were harvested for histological, immuno histochemical and western blot analysis. 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2'-azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radical scavenging activity was depended on steaming hours. RG0F0 and RG8F3 (ginseng-8 h steamed and fermented by Saccharomyces cerevisiae) were showed antioxidants effect in DPPH and ABTS radical scavenging activity. Component amounts according to steaming hours. 8 h steamed red ginseng had the most ingredients of ginsenoside. Treatments with RG8F3 reduced cisplatin-induced nephrotoxicity in the mice resulting in increase of GSH and decrease of ROS, BUN, creatinine, and inflammatory mediators. This result seems to be involved with the restriction of the inflammation in the kidney. Therefore, fermented red ginseng might have therapeutic efficacy in reduce kidney injury induced by cisplatin treatment.

홍삼은 인삼을 찌고 말리는 과정을 거쳐 제조한 것으로 많은 약리 및 생리활성이 알려져 있다. Cisplatin은 항암제로 사용되고 있으나 부작용으로 골수억제, 위장관계독성, 신경독성, 신독성 등이 보고되어있다. 특히 cisplatin이 신장에 집중적으로 축적됨으로써 투여환자의 25-30%에서 신장독성이 유발된다. 따라서 본 실험에서는 발효홍삼을 이용한 cisplatin의 부작용인 신독성예방효능을 확인하고자 하였다. 시료에 따른 DPPH와 ABTS 라디칼소거능을 실험 결과 RG8F3에서 가장 우수한 소거능을 확인하였고 따라서 RG0SF0와 RG8F3 간의 비교실험이 가능할 것으로 사료되었다. 동물실험은 정상군, 대조군, RG0SF0 투여군 및RG8F3 투여군 4그룹으로 나누었다. 약물투여군은 200 mg/kg/day의 농도로 4일간 투여한 후,cisplatin은 20 mg/kg으로 대조군 및 약물투여군에복강주사하였다. RG8F3 투여한 결과 대조군과 비교하여 GSH의 수치는 증가하였고 ROS, BUN, creatinine 및 염증인자들의 감소를 보였다. 조직학적 결과에서도 신손상으로 인한 변형이 거의 없었다. 결론적으로 발효홍삼은 cisplatin으로 유발되는 신 손상 예방에 유의한 효과를 보이는 것으로 사료된다.

Keywords

References

  1. Ahn DW, Kim SR, Ha DH, Kim SH (2007) Mechanism of Amelipration of Cisplatin Nephrotoxicity by Procaine Treatment in Mice. Korean J Anesthesiol 52: 318-327 https://doi.org/10.4097/kjae.2007.52.3.318
  2. Appenroth D, Frob S, Kersten L, Splinter FK, Winnefeld K (1997) Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol 71: 677-683 https://doi.org/10.1007/s002040050444
  3. Bae EA, Han MJ, Choo MK, Park SY, Kim DH (2002) Metabolism of 20(S)-and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biological & Pharmaceutical Bulletin 25: 58-63 https://doi.org/10.1248/bpb.25.58
  4. Bae EA, Han MJ, Kim EJ, Kim DH (2004) Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Archives of pharmacal research 27: 61-67 https://doi.org/10.1007/BF02980048
  5. Bae EA, Park SY, KIM DH (2000) Constitutive. BETA.-Glucosidases Hydrolyzing Ginsenoside Rb1 and Rb2 from Human Intestinal Bacteria. Biological and Pharmaceutical Bulletin 23: 1481-1485 https://doi.org/10.1248/bpb.23.1481
  6. Baek SH, Piao XL, Lee UJ, Kim HY, Park JH (2006) Reduction of cisplatin-induced nephrotoxicity by ginsenosides isolated from processed ginseng in cultured renal tubular cells. Biological and Pharmaceutical Bulletin 29: 2051-2055 https://doi.org/10.1248/bpb.29.2051
  7. Davis CA, Nick HS, Agarwal A (2001) Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 12: 2683-2690
  8. Gandara DR, Perez EA, Phillips WA, Lawrence HJ, DeGregorio M (1989) Evaluation of cisplatin dose intensity: current status and future prospects. Anticancer Res 9: 1121-1128
  9. Glover D, Grabelsky S, Fox K, Weiler C, Cannon L, Glick J (1989) Clinical trials of WR-2721 and cis-platinum. Int J Radiat Oncol Biol Phys 16: 1201-1204 https://doi.org/10.1016/0360-3016(89)90283-6
  10. Han SY, Yeo SH, Jeong ST, Choi HS, Baek SY, Park HY (2012) Status and Prospect of plant Fermented Liquid in Korea. Food Science and Industry 45: 31-43
  11. Hasegawa H, Sung JH, Benno Y (1997) Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta medica 63: 436-440 https://doi.org/10.1055/s-2006-957729
  12. Howell SB, Taetle R (1980) Effect of sodium thiosulfate on cisdichloro diammineplatinum (II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep 64: 611-616
  13. Ju SM, Kim SH, Kim YM, Jeon BH, Kim WS (2013) Machanism of Cisplatin-induced Apoptosis and Bojungbangam-tang-mediated Anti-apoptotic Effect on Cell Proliferation in Rat Mesangial Cells. Korean J Oriental Physiology & Pathology 27: 43-48
  14. Jung KW, Won YJ, Kong HJ, Oh CM, Cho HS, Lee DH, Lee KH (2015) Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012. Cancer Res Treat 47: 127-141 https://doi.org/10.4143/crt.2015.060
  15. Kim DG, Kim KJ, Ju SM, Kim YI, Choi HS, Keum KS, Kim WS, Gao YA, Jeon BH (2003) Protective effect of Ganopoly and Ganopoly/C+ on nephrotoxicity induced by cisplatin in rats. Korean J Oriental Physiology & Pathology 17: 316-325
  16. Kim HG, Kim KY, Cha CJ (2007) Screening for ginsengfermenting microoragnisms capable of biotransforming ginsenosides. Kor J Microbiol 43: 142-146
  17. Kim HJ, Kwak IA, Kim HJ, Ahn JS, Son YB (2013) A Study on the Amendment Scheme of Ginsenoside Content Standard Regulation for Red Ginseng Products in Korea. Journal of Food Hygiene and Safety 28: 24-30 https://doi.org/10.13103/JFHS.2013.28.1.024
  18. Kim HJ, Seo MH, Lee EK, Cho HE, Choi YH, Lee KN, Chong MS (2009) Effect of Fermented Red Ginseng Extracts on Physiological Activity and Blood Glucose Level in Streptozotocin Induced Diabetic Rats. Korean J Oriental Physiology & Pathology 23: 1087-1094
  19. Kim JY, Kim CH (2014) Effect of Zizyphi Spinosae Extract on Cisplatin and t-Butylhydroperoxide Induced Acute Renal Failure in Rabbits. Journal of Life Science 24: 777-783 https://doi.org/10.5352/JLS.2014.24.7.777
  20. Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Rorth M, Krarup C (2007) Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies. Brain 130: 1076-1088
  21. Moncada S, Palmer RML, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological reviews 43: 109-142
  22. Nam KY (2005) The Comoarative Understanding between Red Ginseng and White Ginsengs, Processed Ginsengs (Panax ginseng C.A. Meyer). J Ginseng Res 29: 1-18 https://doi.org/10.5142/JGR.2005.29.1.001
  23. Naziroglu M, Karaoglu A, Aksoy AO (2004) Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver, and lens tissues in rats. Toxicology 195: 221-230 https://doi.org/10.1016/j.tox.2003.10.012
  24. Nicolao P, Giometto B (2003) Neurological toxicity of ifosfamide. Oncology 65: 11-16 https://doi.org/10.1159/000073352
  25. Nishijo H, Uwano T, Zhong Y M, Ono T (2004). Proof of the mysterious efficacy of ginseng: basic and clinical trials: effects of red ginseng on learning and memory deficits in an animal model of amnesia. Journal of pharmacological sciences 95: 145-152 https://doi.org/10.1254/jphs.FMJ04001X3
  26. Oriana S, Bohm S, Spatti G, Zunino F, Di Re F (1987) A preliminary clinical experience with reduced glutathione as protector against cisplatin-toxicity. Tumori 73: 337-340 https://doi.org/10.1177/030089168707300403
  27. Ozols RF, Corden BJ, Jacob J, Wesley MN, Ostchega Y, Young RC (1984) High-dose cisplatin in hypertonic saline. Ann Intern Med 100: 19-24 https://doi.org/10.7326/0003-4819-100-1-19
  28. Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney international 73: 994-1007 https://doi.org/10.1038/sj.ki.5002786
  29. Park CK, Jeon BS, Yang JW (2003) The Chemical Components of Korean Ginseng. Food Industry and Nutrition 8: 10-23
  30. Park SY, Choung SY (1998) Inhibitory Effect of Schizandrin on Nephrotoxicity of Cisplatin. Korean J Environ. Toxicol 13: 125-131
  31. Parlakpinar H, Sahna E, Ozer MK, Ozuglurlu F, Vardi N, Acet A (2002) Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury. J Pineal Res 33: 161-166 https://doi.org/10.1034/j.1600-079X.2002.02910.x
  32. Ramesh G, Reeves WB (2002) TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. Journal of Clinical Investigation 110: 835-842 https://doi.org/10.1172/JCI200215606
  33. Safirstein R, Miller P, Guttenplan JB (1984) Uptake and metabolism of cisplatin by rat kidney. Kidney Int 25: 753-8 https://doi.org/10.1038/ki.1984.86
  34. Safirstein R, Winston J, Goldstein M, Moel D, Dikman S, Guttenplan J (1986) Cisplatin nephrotoxicity. American Journal of Kidney Diseases 8: 356-367 https://doi.org/10.1016/S0272-6386(86)80111-1
  35. Storck M, Schilling M, Prestel R, Abendroth D, Burkhardt K, Hammer C (1994) Production of proinflammatory cytokines and adhesion molecules in exvivo xenogeneic kidney perfusion. Transplant International 7: 647-649 https://doi.org/10.1111/j.1432-2277.1994.tb01464.x
  36. Sutton TA, Molitoris BA (1998) Mechanisms of cellular injury in ischemic acute renal failure. Seminars in Nephrology 18: 490-497
  37. Yoon SS (2008) Management of Hematologic Malignancies. J Korean Oncol Nurs 8: 67-75

Cited by

  1. 떫은감과 포제 떫은감의 최종당화산물 생성 억제를 통한 피부 탄력 개선 효과 vol.32, pp.4, 2017, https://doi.org/10.6116/kjh.2017.32.4.17